30 related articles for article (PubMed ID: 8095179)
1. A Review of the Antimicrobial Properties of Cyanobacterial Natural Products.
Cock IE; Cheesman MJ
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894609
[TBL] [Abstract][Full Text] [Related]
2. Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.
Chlipala GE; Mo S; Orjala J
Curr Drug Targets; 2011 Oct; 12(11):1654-73. PubMed ID: 21561419
[TBL] [Abstract][Full Text] [Related]
3. Mechanism targeted discovery of antitumor marine natural products.
Nagle DG; Zhou YD; Mora FD; Mohammed KA; Kim YP
Curr Med Chem; 2004 Jul; 11(13):1725-56. PubMed ID: 15279579
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product.
Smith CD; Prinsep MR; Caplan FR; Moore RE; Patterson GM
Oncol Res; 1994; 6(4-5):211-8. PubMed ID: 7841544
[TBL] [Abstract][Full Text] [Related]
5. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides.
Zhang X; Minale L; Zampella A; Smith CD
Cancer Res; 1997 Sep; 57(17):3751-8. PubMed ID: 9288783
[TBL] [Abstract][Full Text] [Related]
6. Differential interactions of cytochalasins with P-glycoprotein.
Zilfou JT; Smith CD
Oncol Res; 1995; 7(9):435-43. PubMed ID: 8835287
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by two novel indole derivatives.
Kadam S; Maus M; Poddig J; Schmidt S; Rasmussen R; Novosad E; Plattner J; McAlpine J
Cancer Res; 1992 Sep; 52(17):4735-40. PubMed ID: 1355008
[TBL] [Abstract][Full Text] [Related]
9. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
Smith CD; Carmeli S; Moore RE; Patterson GM
Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells.
Savas B; Cole SP; Akoglu TF; Pross HF
Nat Immun; 1992; 11(4):177-92. PubMed ID: 1358293
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance.
Fine RL; Chabner BA
Cancer Chemother Biol Response Modif; 1987; 9():81-92. PubMed ID: 2908588
[No Abstract] [Full Text] [Related]
12. Multidrug resistance.
Fine RL
Cancer Chemother Biol Response Modif; 1988; 10():73-84. PubMed ID: 2908587
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
